Pharmacokinetics of parenteral and oral melperone in man

@article{Borgstrm2004PharmacokineticsOP,
  title={Pharmacokinetics of parenteral and oral melperone in man},
  author={L. Borgstr{\"o}m and H. Larsson and L. Molander},
  journal={European Journal of Clinical Pharmacology},
  year={2004},
  volume={23},
  pages={173-176}
}
  • L. Borgström, H. Larsson, L. Molander
  • Published 2004
  • Medicine
  • European Journal of Clinical Pharmacology
  • SummaryThe pharmacokinetics of melperone (Buronil®, Ferrosan, Sweden) was studied after administration of various parenteral and oral doses to man. After parenteral administration, the data could be fitted to a two-compartment model, but after oral dosing the distribution phase could not be separated from the elimination phase, and so an one-compartment model gave the best fit. The half-lives were about 3–4 h, except after intramuscular injection, when the half-life was about 6 h. The… CONTINUE READING

    Figures, Tables, and Topics from this paper.

    Explore Further: Topics Discussed in This Paper

    Butyrophenone und strukturanaloge Verbindungen
    • 1

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 17 REFERENCES
    Symbols in pharmacokinetics
    • 34
    A clinical study of the effects of melperone and placebo on behavioural abnormalities in mentally retarded patients
    • 1979
    Ambulante Erfahrungen mit Melperon bei psychovegetativen Beschwerden unter kontrollierten Bedingungen
    • 1980
    Buronil ®, et nytt butyrophenonderivat ved akutte psykiatriska lidelser. (Buronil, a new butyrophenone derivative in acute psychiatric illnesses
    • 1967